Spain· ES:55577

TRONOXAL 1.000 MG POLVO PARA SOLUCIÓN PARA PERFUSIÓN

A medicinal product containing ifosfamida, registered in Spain by Baxter S.L..

Checked against AEMPS CIMA (Spain) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ifosfamidaAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

AEMPS CIMA (Spain)

Active substance: ifosfamida
Manufacturer: Baxter S.L.
Country: Spain (ES)
ATC code: —
Reimbursed: Not published by this register
Source register: AEMPS CIMA (Spain)
Last checked: September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ifosfamida in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ifosfamida products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Holoxan
Belgium · Holoxan
Bulgaria · Холоксан
Czechia · Holoxan
Germany · Holoxan, Ifo-Cell
Denmark · Holoxan
Estonia · Holoxan
Finland · Holoxan
France · Holoxan, Ifosfamide Eg
United Kingdom (Northern Ireland) · Ifosfamide Baxter Healthcare
Greece · Holoxan
Croatia · Holoxan
Hungary · Holoxan
Ireland · Mitoxana
Iceland · Holoxan
Italy · Holoxan
Lithuania · Holoxan
Luxembourg · Holoxan
Latvia · Holoxan
Malta · Mitoxana
Netherlands · Holoxan
Norway · Holoxan
Poland · Holoxan
Portugal · Holoxan
Romania · Holoxan
Sweden · Holoxan
Slovenia · Holoxan
Slovakia · Holoxan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c871618a-c69d-4ea9-b002-85db5e0e59bf
GET /v1/drugs/c871618a-c69d-4ea9-b002-85db5e0e59bf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Uso Hospitalario",
  "estado": "{\"aut\":428536800000}",
  "nregistro": "55577",
  "substance": "ifosfamida"
}

API reference MCP server Plans

See everything about ifosfamida.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console